Biotech · Platform biotech deck
Platform biotech decks that prove the platform, not one program.
A platform company must show that its technology produces more than one good program. The deck has to separate what the platform proves from what any single asset proves.
Fixed prices. No calls: you brief us in writing and comment in writing.
Platform
Several programs from one discovery engine
Illustration only. Any figures are invented for this sample slide.
Who reads it
Investors weighing platform breadth against focus.
Turnaround
5 business days for a design rebuild; 3 business days for an audit.
How it differs
How a platform biotech deck differs from a general pitch deck
A general startup deck tells one product story. A platform biotech deck tells two at once: the engine, and what the engine has made. Investors look for proof that the engine works independently of any single program, and for one asset close enough to human data to anchor value. Partnerships count only when their structure shows the platform is valued, so deal type matters more than logos. Ownership of each program and of platform improvements must be clear, because partner rights change what an investor actually owns.
Slide by slide
What goes in a platform biotech deck
- 01
The platform
What it does that others cannot.
- 02
Proof across programs
Evidence from more than one target or indication.
- 03
Lead assets
The programs closest to value.
- 04
Partnering strategy
Which programs you keep and which you partner.
- 05
Partnerships so far
Signed agreements, as you may disclose them.
- 06
Platform improvement
How each program makes the next one better.
- 07
Pipeline
Programs by stage.
- 08
Use of funds
Platform and program spending separated.
The questions behind every slide
What readers of a platform biotech deck ask
Each answer names the slide or document where it belongs. If a question has no home in your deck, the reader will ask it in writing, or stop reading.
- 1
What can the platform do that a well-funded team with standard tools cannot?
The platform slide, with a direct comparison against the standard method.
- 2
Is the time and cost from target to candidate falling with each program?
The platform improvement slide, showing cycle time or cost per candidate across programs, in relative terms if needed.
- 3
Which programs do you own outright, and which carry partner rights?
The pipeline slide should mark ownership on every program, with detail in a business development appendix.
- 4
Does each partnership validate the platform, or is it fee-for-service work?
The partnerships slide should state the deal type for each: research collaboration, option or license, with terms only as you may disclose.
- 5
What data does the platform generate that others cannot buy?
The platform slide, describing the dataset by type and how it grows with each program.
- 6
When will the first internal asset reach human data?
The lead assets slide, with the milestone and its funding source.
- 7
What is left of the platform's value if the lead asset fails?
The proof across programs slide, showing evidence that does not depend on the lead asset.
- 8
Who owns improvements made to the platform during a partnered program?
The partnering strategy slide, with a terms summary in the appendix approved by your counsel.
Headline rewrites
Slide titles that say something.
A reader skims headlines first. A label tells them the topic; a sentence tells them the point. Bracketed figures are placeholders for your own numbers.
Before
Our platform
After
One engine produced [X] candidates against [X] targets in [X] years
Before
Partnerships
After
[X] partners paid to access the platform, and we kept the rights to [area]
Before
Pipeline
After
[X] wholly owned programs, the first reaching the clinic in [year]
What we fix
Faults we see in platform biotech deck drafts
Platform claims supported by one program only.
Partnered and internal programs mixed.
No clear first product.
What you receive
Documents we produce
- Investor deck
- Non-confidential deck
- Business development deck
Every file is delivered editable, in PowerPoint, Google Slides or Keynote, with a PDF for sending. A platform biotech deck rebuild starts at $3,500; the full Raise Set with one-pager and teaser is $10,000.
Format
Length, versions and appendix
- Length
- Often 15 to 22 main slides, since the platform and the programs both need room.
- Send-ahead version
- Send a non-confidential version for first contact. Investors and pharma business development teams often need different versions.
- Presented version
- Show the platform once, then prove it through two programs. Return to the platform at the end to show what the next program costs.
What belongs in the appendix
- Program-by-program data
- Platform metrics and how they are measured
- Partnership terms as disclosable
- Patent families for platform and assets
- Dataset description
- Scientific advisors
Before you send it
Platform biotech deck checklist
- Every program is labeled owned, partnered or under option.
- Platform evidence comes from more than one program or target.
- Each platform metric states how it is measured.
- Partnership terms appear only as disclosure agreements allow.
- A first product is named.
- Claims such as any target or any disease are removed unless data supports them.
- Partner logos appear only with written permission.
- Non-confidential and business development versions leave out proprietary method detail.
Glossary
Terms used in a platform biotech deck
- Platform company
- A biotech whose core asset is a repeatable technology for making or finding many drug candidates.
- Asset-centric company
- A biotech built around one drug or a small set of drugs rather than a discovery engine.
- Option-to-license deal
- An agreement that gives a partner the right, but not the duty, to license a program later on agreed terms.
- Upfront payment
- Money a partner pays when a deal is signed, before any milestone is reached.
- Milestone payment
- Money due when a program reaches an agreed point, such as a trial start or a regulatory filing.
- Royalty
- A share of product sales paid to the licensor after a licensed drug reaches market.
Your written brief
What to send us for a platform biotech deck
No call needed. Send what you have; missing items are listed in our written reply, and nothing is invented to fill a gap.
- 01A description of the platform steps and what is proprietary
- 02Data from every program, with study designs
- 03Program ownership and partner rights
- 04Partnership summaries you may disclose
- 05Platform metrics such as time, cost or hit rate, with method
- 06Patent families for the platform and the assets
- 07Budget split between platform and programs
- 08Current deck
Packages
Four packages, fixed prices.
Deck Audit
$1,500
3 business days
A written verdict on the deck you have, before you send it to anyone.
- Slide-by-slide notes inside your file
- The fixes that matter most, in order
- Story, numbers and design, each assessed
- The investor questions your deck leaves open
One deck, up to 20 slides. No redesign included.
Choose Deck AuditInvestor Finish
$3,500
5 business days
Your draft, rebuilt to investor standard. Design only.
- Up to 15 slides rebuilt
- Charts redrawn from your data
- Your brand applied throughout
- One written revision round
- Editable PowerPoint, Google Slides or Keynote
Design only: your wording and slide order stay as they are.
Choose Investor FinishFinish + Story
$6,500
8 business days
We restructure the argument, rewrite the headlines, then rebuild the deck.
- Up to 20 slides
- Narrative restructured from your draft and notes
- Headlines rewritten as full-sentence points
- Send-ahead PDF version
- Two written revision rounds
We work from your facts. No market research or financial modeling.
Choose Finish + StoryRaise Set
$10,000
12 business days
Everything a raise needs, in one matching set.
- Up to 30 slides plus appendix
- Investor one-pager
- Short teaser version for cold outreach
- Three written revision rounds
- All source files
No investor introductions, fundraising or legal advice.
Choose Raise SetNot included in any package: Calls or meetings · Market research · Financial modeling or valuation · Investor introductions · Fundraising, legal or securities advice. Extra slides and extra revision rounds are quoted in writing before we start them.
Questions, answered.
Lead with the platform or the lead asset?+
With the platform if you have evidence across programs; with the asset if you do not yet.
How much does a pitch deck cost here?+
A written Deck Audit is $1,500. Investor Finish, a design rebuild of up to 15 slides, is $3,500. Finish + Story, with the argument restructured, is $6,500. Raise Set, up to 30 slides with a one-pager and teaser, is $10,000.
How long does it take?+
Three business days for an audit, five for Investor Finish, eight for Finish + Story and twelve for Raise Set, counted from payment and a complete brief.
Is there a call?+
No. No package includes a call or meeting. You brief us in writing and comment in writing.
What do I need to send?+
Your draft deck in any editable format, or notes if you chose a package with writing, plus a few lines on who will read it and what you are asking for.
How do I pay?+
By card, through a secure payment link we send once scope and delivery date are confirmed in writing.
More decks in Biotech
All 4 Biotech decksOther categories
- Real estate
- SaaS and software
- AI startups
- Fintech
- Healthcare
- Climate and energy
- Hardware and robotics
- Consumer brands
Pitch deck design for biotech companies: science, pipeline and milestones made clear for investors who are not all specialists. Fixed packages from $3,500.
Further reading
Sources we read when writing this page. General information only; not legal, tax or investment advice.
Have a draft? Send it today.
Choose a package, link your deck and write a few lines about who it is for. You get scope, a delivery date and a payment link in writing.